These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22238358)

  • 21. Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan.
    Nakagawa N; Manya H; Toda T; Endo T; Oka S
    J Biol Chem; 2012 Aug; 287(36):30823-32. PubMed ID: 22801424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fer is a downstream effector of insulin and mediates the activation of signal transducer and activator of transcription 3 in myogenic cells.
    Taler M; Shpungin S; Salem Y; Malovani H; Pasder O; Nir U
    Mol Endocrinol; 2003 Aug; 17(8):1580-92. PubMed ID: 12738762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent Advances in α-dystroglycanopathy].
    Kuga A; Kanagawa M; Toda T
    Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FER promotes cell migration via regulating JNK activity.
    Li P; Ma Z; Yu Y; Hu X; Zhou Y; Song H
    Cell Prolif; 2019 Sep; 52(5):e12656. PubMed ID: 31264309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
    Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
    Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal glycosylation of dystroglycan in human genetic disease.
    Hewitt JE
    Biochim Biophys Acta; 2009 Sep; 1792(9):853-61. PubMed ID: 19539754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
    Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
    Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
    Endo T
    Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian
    Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
    J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.
    Huang Q; Miller MR; Schappet J; Henry MD
    Cancer Biol Ther; 2015; 16(1):125-36. PubMed ID: 25455932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.
    Rocha J; Zouanat FZ; Zoubeidi A; Hamel L; Benidir T; Scarlata E; Brimo F; Aprikian A; Chevalier S
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):140-9. PubMed ID: 23906537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are required for the Fer tyrosine kinase activity.
    Hikri E; Shpungin S; Nir U
    Cell Signal; 2009 Apr; 21(4):588-96. PubMed ID: 19159681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion.
    Stanicka J; Rieger L; O'Shea S; Cox O; Coleman M; O'Flanagan C; Addario B; McCabe N; Kennedy R; O'Connor R
    Oncogene; 2018 Jun; 37(23):3131-3150. PubMed ID: 29540831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of feline sarcoma‑related protein in the viability and apoptosis of bladder cancer cells.
    Hu X; Guo Z; Xu J; Mei X; Bi M; Jiang F; Yu D; Zhong C
    Mol Med Rep; 2019 Jun; 19(6):5219-5226. PubMed ID: 31059042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis.
    Zhang HZ; Xia XY; Zhu F; Shen H; Song K; Shang ZJ
    J Oral Maxillofac Surg; 2014 Jun; 72(6):1106-18. PubMed ID: 24629698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inside and out of dystroglycan post-translational modification.
    Moore CJ; Winder SJ
    Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of Fer induces ROS levels accompanied by ATM and p53 activation in colon carcinoma cells.
    Makovski A; Yaffe E; Shpungin S; Nir U
    Cell Signal; 2012 Jul; 24(7):1369-74. PubMed ID: 22434045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.
    Zhang P; Yang Y; Candiello J; Thorn TL; Gray N; Halfter WM; Hu H
    Matrix Biol; 2013 Apr; 32(3-4):196-207. PubMed ID: 23454088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.
    Willer T; Inamori K; Venzke D; Harvey C; Morgensen G; Hara Y; Beltrán Valero de Bernabé D; Yu L; Wright KM; Campbell KP
    Elife; 2014 Oct; 3():. PubMed ID: 25279699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.